Superovulatory responses of cattle

Effects of GnRH treatment on superovulatory responses of dairy cows

Twenty-eight Holstein cows were randomly divided into two groups. Group received 50 mg of FSH-P intramuscularly in declining doses for five days. Cows in group II received the same treatment as those in Group I but were also administered 250 ug of GnRH on the day of expected estrus. Neither the mean number of corpora lutea palpated nor the mean number of embryos recovered nonsurgically was different (P0.05) between treatments. However, administration of GnRH resulted in a higher fertilization rate and recovery of more developing embryos.

Superovulation of beef heifers with Pergonal (HMG): A dose response trial

A study was designed to establish a dose-response curve for Pergonal (Human Menopausal Gonadotrophin) and to compare its efficacy in inducing superovulation with commercial FSH-P. A recognized treatment schedule for HMG of two ampoules at 0, 12, 24 and 36 hours and one ampoule at 48, 60, 72, 84, 96 and 108 hours was considered to be our 100% effective dose level. Fifty mature cycling cross-bred beef heifers were superovulated on day 10 +/- 1 of their cycle. Treatment groups were HMG I (200% dose), HMG II (100% dose), HMG III )50% dose), HMG IV (25% dose) and FSH-P (total dose 32 mg). All groups received 500 ug of cloprostenol 72 hours after initiation of treatments. The heifers were observed for onset of estrus and inseminated at 12, 24 and 36 hours. All heifers were slaughtered on day 7 post-estrus and their reproductive tracts removed for processing. All heifers were bled once daily for progesterone estimation and four times daily for two days beginning 24 hours after cloprostenol injection, for luteinizing hormone and estradiol-17beta estimations. A dose response to HMG was demonstrated for number of corpora lutea and all classes of ova/embryos. HMG II (100% dose) closely approximated the optimum dose for superovulation. There was no significant difference between the HMG II group and the FSH-P group for mean number of transferable embryos. The 200% HMG dose did not increase the numbers of ovulations or ova recovered but did decrease the numbers of fertilized and transferable ova.

The effects of dietary monensin sodium upon superovulation and embyro viability from mature cows

Twelve mature British crossbred cows were randomly divided into two equal groups. Group A was fed no monensin while group B received 200 mg/head/day. Superovulation with follicle stimulating hormone (FSH) was attempted in all cows between days 9 and 11 of the estrous cycle. The number of corpora lutea per treated cow was significantly greater (P<0.05) than in controls. The number of ova recovered per cow was not significantly different between the two groups. Mean total luteal weight was significantly greater for monensin-treated cows. Embryo viability was determined using fluorescein diacetate (FDA) and was found to be similar in both groups.

Dose of FSH-P as a source of variation in embryo production from superovulated cows

Various superovulation treatments were evaluated retrospectively in a commercial embryo transfer program. When it appeared that embryo production was dependent on the dose of FSH-P, a dose response curve to FSH-P was developed and embryo production compared using several treatment regimes. There was a significant effect of dose of FSH-P on embryo production in superovulated cows. At doses in excess of 28 mg, embryo production declined from 5.9 transferable embryos per collection (28 mg) to 2.7 (60 mg). Total embryos collected declined from 14.9 to 6.8 and the percent transferable from 57% to 40%. There was no advantage in using a five-day treatment over a four-day treatment regimen or in using a level over a declining dose regimen. There was a large individual variation in cow response rendering decisions on treatment changes based on single records unreliable. The percentage of zero collections increased with dose rate. Adoption of a 28-mg dose rate in commercial donors resulted in the embryo production forecast by these studies.

The day of the estrous cycle that FSH is started and superovulation in cattle

A total of 993 commercial donor cows were superovulated with 28 mg FSH-P. The first injection of FSH-P was administered on one of days 9 through 13 of the donor's estrous cycle. The day that FSH was started did not affect total embryos collected, the number of transferable embryos or the percent transferable. These results did not support the current hypothesis that because the population of antral and preantral follicles in the ovaries on days 9 and 10 is higher, best embryo production should be achieved by starting donor cows on day 9 or 10 of the estrous cycle.

Embryo production in superovulated cows: Transferable embryos correlated with total embryos

Embryo production was studied in 1,263 donor cows. The number of transferable (good) embryos per collection was highly correlated with the total embryos and ova in a collection (r = 0.64). Total ova and embryos per collection averaged 10.1 with a range from 0-70; the number of good embryos averaged 4.5 with a range from 0-37. Of all collections, 15.3% failed to yield any embryos or ova, and 32.4% did not yield any good embryos. The percentage of good embryos averaged 46.1 while the ratio of good embryos produced (5,680) to total embryos and ova produced (12,699) was 0.45.